Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Calcitonin Gene Related Peptide Type 1 Receptor market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Calcitonin Gene Related Peptide Type 1 Receptormarket, defines the market attractiveness level of Calcitonin Gene Related Peptide Type 1 Receptor market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Calcitonin Gene Related Peptide Type 1 Receptor industry, describes the types of Calcitonin Gene Related Peptide Type 1 Receptor market, the applications of major players and the market size, and deeply analyzes the current situation of the global Calcitonin Gene Related Peptide Type 1 Receptor market and the development prospects and opportunities of Calcitonin Gene Related Peptide Type 1 Receptor industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Calcitonin Gene Related Peptide Type 1 Receptor market in Chapter 13.
By Player:
Merck & Co Inc
Eli Lilly and Company
Allergan Plc
Biohaven Pharmaceutical Holding Company Ltd
Fortress Biotech Inc
Teva Pharmaceutical Industries Ltd
Amgen Inc
Vertex Pharmaceuticals Inc
By Type:
AFAP-3
AGN-241689
CGRP
Erenumab
Others
By End-User:
Cardiovascular
Metabolic Disorders
Dental Pain
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Calcitonin Gene Related Peptide Type 1 Receptor Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Calcitonin Gene Related Peptide Type 1 Receptor Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Calcitonin Gene Related Peptide Type 1 Receptor Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Calcitonin Gene Related Peptide Type 1 Receptor Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Calcitonin Gene Related Peptide Type 1 Receptor Market Analysis and Outlook to 2022
-
7.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Consumption (2017-2022)
-
7.2 United States Calcitonin Gene Related Peptide Type 1 Receptor Consumption (2017-2022)
-
7.3 Europe Calcitonin Gene Related Peptide Type 1 Receptor Consumption (2017-2022)
-
7.4 China Calcitonin Gene Related Peptide Type 1 Receptor Consumption (2017-2022)
-
7.5 Japan Calcitonin Gene Related Peptide Type 1 Receptor Consumption (2017-2022)
-
7.6 India Calcitonin Gene Related Peptide Type 1 Receptor Consumption (2017-2022)
-
7.7 South Korea Calcitonin Gene Related Peptide Type 1 Receptor Consumption (2017-2022)
8 Region and Country-wise Calcitonin Gene Related Peptide Type 1 Receptor Market Analysis and Outlook to 2028
-
8.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Consumption Forecast (2022-2028)
-
8.2 United States Calcitonin Gene Related Peptide Type 1 Receptor Consumption Forecast (2022-2028)
-
8.3 Europe Calcitonin Gene Related Peptide Type 1 Receptor Consumption Forecast (2022-2028)
-
8.4 China Calcitonin Gene Related Peptide Type 1 Receptor Consumption Forecast (2022-2028)
-
8.5 Japan Calcitonin Gene Related Peptide Type 1 Receptor Consumption Forecast (2022-2028)
-
8.6 India Calcitonin Gene Related Peptide Type 1 Receptor Consumption Forecast (2022-2028)
-
8.7 South Korea Calcitonin Gene Related Peptide Type 1 Receptor Consumption Forecast (2022-2028)
9 Global Calcitonin Gene Related Peptide Type 1 Receptor Market Outlook by Types and Applications to 2022
-
9.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global AFAP-3 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global AGN-241689 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global CGRP Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Erenumab Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Cardiovascular Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Metabolic Disorders Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Dental Pain Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Calcitonin Gene Related Peptide Type 1 Receptor Market Outlook by Types and Applications to 2028
-
10.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global AFAP-3 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global AGN-241689 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global CGRP Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Erenumab Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Cardiovascular Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Metabolic Disorders Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Dental Pain Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Calcitonin Gene Related Peptide Type 1 Receptor Import and Export Analysis (Top 5 Countries)
-
11.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Calcitonin Gene Related Peptide Type 1 Receptor Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Calcitonin Gene Related Peptide Type 1 Receptor Market Competitive Analysis
-
14.1 Merck & Co Inc
-
14.1.1 Merck & Co Inc Company Details
-
14.1.2 Merck & Co Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Merck & Co Inc Calcitonin Gene Related Peptide Type 1 Receptor Product and Service
-
14.2 Eli Lilly and Company
-
14.2.1 Eli Lilly and Company Company Details
-
14.2.2 Eli Lilly and Company Calcitonin Gene Related Peptide Type 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Eli Lilly and Company Calcitonin Gene Related Peptide Type 1 Receptor Product and Service
-
14.3 Allergan Plc
-
14.3.1 Allergan Plc Company Details
-
14.3.2 Allergan Plc Calcitonin Gene Related Peptide Type 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Allergan Plc Calcitonin Gene Related Peptide Type 1 Receptor Product and Service
-
14.4 Biohaven Pharmaceutical Holding Company Ltd
-
14.4.1 Biohaven Pharmaceutical Holding Company Ltd Company Details
-
14.4.2 Biohaven Pharmaceutical Holding Company Ltd Calcitonin Gene Related Peptide Type 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Biohaven Pharmaceutical Holding Company Ltd Calcitonin Gene Related Peptide Type 1 Receptor Product and Service
-
14.5 Fortress Biotech Inc
-
14.5.1 Fortress Biotech Inc Company Details
-
14.5.2 Fortress Biotech Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Fortress Biotech Inc Calcitonin Gene Related Peptide Type 1 Receptor Product and Service
-
14.6 Teva Pharmaceutical Industries Ltd
-
14.6.1 Teva Pharmaceutical Industries Ltd Company Details
-
14.6.2 Teva Pharmaceutical Industries Ltd Calcitonin Gene Related Peptide Type 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Teva Pharmaceutical Industries Ltd Calcitonin Gene Related Peptide Type 1 Receptor Product and Service
-
14.7 Amgen Inc
-
14.7.1 Amgen Inc Company Details
-
14.7.2 Amgen Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Amgen Inc Calcitonin Gene Related Peptide Type 1 Receptor Product and Service
-
14.8 Vertex Pharmaceuticals Inc
-
14.8.1 Vertex Pharmaceuticals Inc Company Details
-
14.8.2 Vertex Pharmaceuticals Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Vertex Pharmaceuticals Inc Calcitonin Gene Related Peptide Type 1 Receptor Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Calcitonin Gene Related Peptide Type 1 Receptor
-
Figure Calcitonin Gene Related Peptide Type 1 Receptor Picture
-
Table Global Calcitonin Gene Related Peptide Type 1 Receptor Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Calcitonin Gene Related Peptide Type 1 Receptor Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Calcitonin Gene Related Peptide Type 1 Receptor Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Calcitonin Gene Related Peptide Type 1 Receptor Consumption by Country (2017-2022)
-
Figure United States Calcitonin Gene Related Peptide Type 1 Receptor Consumption and Growth Rate (2017-2022)
-
Table Europe Calcitonin Gene Related Peptide Type 1 Receptor Consumption and Growth Rate (2017-2022)
-
Figure China Calcitonin Gene Related Peptide Type 1 Receptor Consumption and Growth Rate (2017-2022)
-
Figure Japan Calcitonin Gene Related Peptide Type 1 Receptor Consumption and Growth Rate (2017-2022)
-
Figure India Calcitonin Gene Related Peptide Type 1 Receptor Consumption and Growth Rate (2017-2022)
-
Figure South Korea Calcitonin Gene Related Peptide Type 1 Receptor Consumption and Growth Rate (2017-2022)
-
Figure Global Calcitonin Gene Related Peptide Type 1 Receptor Consumption Forecast by Country (2022-2028)
-
Figure United States Calcitonin Gene Related Peptide Type 1 Receptor Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Calcitonin Gene Related Peptide Type 1 Receptor Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Calcitonin Gene Related Peptide Type 1 Receptor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Calcitonin Gene Related Peptide Type 1 Receptor Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Calcitonin Gene Related Peptide Type 1 Receptor Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Calcitonin Gene Related Peptide Type 1 Receptor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global AFAP-3 Consumption and Growth Rate (2017-2022)
-
Figure Global AGN-241689 Consumption and Growth Rate (2017-2022)
-
Figure Global CGRP Consumption and Growth Rate (2017-2022)
-
Figure Global Erenumab Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiovascular Consumption and Growth Rate (2017-2022)
-
Figure Global Metabolic Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Dental Pain Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global AFAP-3 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global AGN-241689 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CGRP Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Erenumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiovascular Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Metabolic Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dental Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Calcitonin Gene Related Peptide Type 1 Receptor Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Calcitonin Gene Related Peptide Type 1 Receptor Export by Region (Top 5 Countries) (2017-2028)
-
Table Merck & Co Inc (Foundation Year, Company Profile and etc.)
-
Table Merck & Co Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co Inc Calcitonin Gene Related Peptide Type 1 Receptor Product and Service
-
Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly and Company Calcitonin Gene Related Peptide Type 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company Calcitonin Gene Related Peptide Type 1 Receptor Product and Service
-
Table Allergan Plc (Foundation Year, Company Profile and etc.)
-
Table Allergan Plc Calcitonin Gene Related Peptide Type 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Plc Calcitonin Gene Related Peptide Type 1 Receptor Product and Service
-
Table Biohaven Pharmaceutical Holding Company Ltd (Foundation Year, Company Profile and etc.)
-
Table Biohaven Pharmaceutical Holding Company Ltd Calcitonin Gene Related Peptide Type 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biohaven Pharmaceutical Holding Company Ltd Calcitonin Gene Related Peptide Type 1 Receptor Product and Service
-
Table Fortress Biotech Inc (Foundation Year, Company Profile and etc.)
-
Table Fortress Biotech Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Fortress Biotech Inc Calcitonin Gene Related Peptide Type 1 Receptor Product and Service
-
Table Teva Pharmaceutical Industries Ltd (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Industries Ltd Calcitonin Gene Related Peptide Type 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Industries Ltd Calcitonin Gene Related Peptide Type 1 Receptor Product and Service
-
Table Amgen Inc (Foundation Year, Company Profile and etc.)
-
Table Amgen Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Inc Calcitonin Gene Related Peptide Type 1 Receptor Product and Service
-
Table Vertex Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table Vertex Pharmaceuticals Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vertex Pharmaceuticals Inc Calcitonin Gene Related Peptide Type 1 Receptor Product and Service
-
